Investigating the relationship between Alzheimer's disease and HIV-related neurological disorders.
Official title: NATIONAL NEUROHIV TISSUE CONSORTIUM (NNTC) - CLINICAL SITE - Alzheimer's disease
Funded at Icahn School of Medicine at Mount Sinai · NIH-11217606 · Data updated 2026-11-12
This study is looking at how Alzheimer's disease and HIV-related brain problems affect each other, and if you have either condition, you can help by sharing some health information and samples, which might lead to better treatments for both.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 23, 2023 |
| Project end | August 22, 2025 |
| Funding year | 2024 |
| Award (this year) | $1,271,052 |
| NIH project number | 75N95023C00015-P00002-9999-3 |
| Project ID | NIH-11217606 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Alzheimer's disease, especially those who are also living with HIV.
✕Less likely to help
Patients who do not have Alzheimer's disease or HIV-related neurological disorders may not benefit from this research.
What this research studies
This research focuses on understanding how Alzheimer's disease interacts with HIV-associated neurological disorders. By examining brain tissues and clinical data, the study aims to uncover the mechanisms that link these conditions. Patients may have the opportunity to contribute to this research by providing biological samples and clinical information, which could lead to better understanding and treatment options for those affected by both Alzheimer's and HIV-related cognitive issues.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic strategies for patients suffering from Alzheimer's disease, particularly those with a history of HIV.
How similar studies have gone: Previous research has shown promising results in understanding the intersection of neurodegenerative diseases and HIV, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Hadijah, Vactor — Icahn School of Medicine at Mount Sinai
- Study coordinator: Hadijah, Vactor
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.